Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA. - Tan, L; Sandhu, S; Lee, R J; Li, J; Callahan, J; Ftouni, S; Dhomen, N; Middlehurst, P; Wallace, A; Raleigh, J; Hatzimihalis, A; Henderson, M A; et al. (Annals of Oncology, 2019)